Topical nasal decongestants
Drug Safety Update
February 2024: Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
June 2017: Pseudoephedrine and ephedrine: regular review of minimising risk of misuse in the UK
December 2014: Over-the-counter cough and cold medicines for children
| Pack |
|---|
| 10 ml |
| Pack |
|---|
| 10 ml |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary